| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 208.602 | 272.428 | 341.785 | 356.604 | 328.827 | 286.432 | 288.188 | 267.301 | 284.875 | 328.591 |
| Total Income - EUR | 208.607 | 272.892 | 342.509 | 356.682 | 338.473 | 292.498 | 295.970 | 267.316 | 284.979 | 333.799 |
| Total Expenses - EUR | 191.572 | 240.502 | 299.060 | 297.812 | 361.603 | 289.315 | 256.004 | 251.726 | 267.498 | 319.323 |
| Gross Profit/Loss - EUR | 17.036 | 32.390 | 43.449 | 58.870 | -23.129 | 3.183 | 39.965 | 15.590 | 17.481 | 14.476 |
| Net Profit/Loss - EUR | 16.517 | 27.277 | 38.319 | 55.292 | -26.514 | 481 | 37.065 | 12.970 | 14.695 | 4.670 |
| Employees | 4 | 5 | 7 | 9 | 9 | 0 | 5 | 5 | 5 | 4 |
Check the financial reports for the company - Vivamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 97.524 | 93.217 | 81.269 | 91.732 | 76.158 | 61.172 | 18.343 | 9.664 | 15.193 | 14.539 |
| Current Assets | 24.203 | 31.436 | 36.469 | 42.637 | 21.442 | 32.210 | 81.846 | 99.852 | 106.582 | 104.346 |
| Inventories | 7.753 | 0 | 0 | -1 | 0 | 0 | 7.243 | 9.910 | 16.569 | 13.877 |
| Receivables | 2.221 | 2.052 | 8.040 | 3.049 | 3.319 | 5.961 | 11.369 | 17.010 | 9.273 | 344 |
| Cash | 14.228 | 29.385 | 28.430 | 39.589 | 18.123 | 26.248 | 63.233 | 72.932 | 80.741 | 90.125 |
| Shareholders Funds | 24.427 | 51.455 | 38.372 | 92.960 | 64.646 | 63.901 | 72.144 | 13.019 | 14.743 | 4.718 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 97.299 | 73.198 | 79.366 | 41.409 | 32.955 | 29.480 | 28.045 | 96.838 | 107.274 | 113.601 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 896 | 654 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vivamed Srl